1. Home
  2. KYTX vs STKS Comparison

KYTX vs STKS Comparison

Compare KYTX & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • STKS
  • Stock Information
  • Founded
  • KYTX 2018
  • STKS 2004
  • Country
  • KYTX United States
  • STKS United States
  • Employees
  • KYTX N/A
  • STKS N/A
  • Industry
  • KYTX
  • STKS Restaurants
  • Sector
  • KYTX
  • STKS Consumer Discretionary
  • Exchange
  • KYTX NYSE
  • STKS Nasdaq
  • Market Cap
  • KYTX 119.7M
  • STKS 109.7M
  • IPO Year
  • KYTX 2024
  • STKS N/A
  • Fundamental
  • Price
  • KYTX $4.33
  • STKS $3.33
  • Analyst Decision
  • KYTX Strong Buy
  • STKS Hold
  • Analyst Count
  • KYTX 5
  • STKS 3
  • Target Price
  • KYTX $19.00
  • STKS $4.83
  • AVG Volume (30 Days)
  • KYTX 599.4K
  • STKS 340.4K
  • Earning Date
  • KYTX 08-11-2025
  • STKS 08-05-2025
  • Dividend Yield
  • KYTX N/A
  • STKS N/A
  • EPS Growth
  • KYTX N/A
  • STKS N/A
  • EPS
  • KYTX N/A
  • STKS N/A
  • Revenue
  • KYTX N/A
  • STKS $799,478,000.00
  • Revenue This Year
  • KYTX N/A
  • STKS $26.92
  • Revenue Next Year
  • KYTX N/A
  • STKS $5.39
  • P/E Ratio
  • KYTX N/A
  • STKS N/A
  • Revenue Growth
  • KYTX N/A
  • STKS 138.50
  • 52 Week Low
  • KYTX $1.78
  • STKS $2.37
  • 52 Week High
  • KYTX $10.08
  • STKS $5.42
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 63.84
  • STKS 37.71
  • Support Level
  • KYTX $3.80
  • STKS $3.31
  • Resistance Level
  • KYTX $4.39
  • STKS $4.12
  • Average True Range (ATR)
  • KYTX 0.39
  • STKS 0.32
  • MACD
  • KYTX 0.05
  • STKS -0.14
  • Stochastic Oscillator
  • KYTX 93.78
  • STKS 5.52

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

Share on Social Networks: